ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (600196 CH)

130
Analysis
Health Care • China
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
•15 Jan 2019 06:58

2018 HK-Connect SouthBound In a Nutshell

Since autumn of 2014, the HK-Shanghai Connect, and later the HK-Shenzhen Connect mechanisms have provided means for mainland investors to buy Hong...

Logo
874 Views
Share
•03 Jul 2018 12:26

Quiddity Weekly H/A: Spread Monitor & Southbound Flows [Week to 29 Jun 2018]

An H/A Spread Monitor Project offering a brief look at recent changes in H-Share and A-Share spreads, Southbound flow and impact, and where the...

Logo
364 Views
Share
bullish•CSPC Pharmaceutical
•07 May 2026 08:30

CSPC Pharma (1093 HK): 2025 Witness VBP Inclusion Impact; Pipeline and Launches Hold Key For Future

​CSPC Pharma's 2025 revenue dropped 10% YoY due to finished drugs decline. Focus on new products, pipeline strength, and high-end market expansion...

Logo
201 Views
Share
•09 Oct 2017 16:15

Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down

We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created...

bearish•Macroeconomics
•24 Jul 2017 19:46

Money Matters: A Fish Called Wanda

Any analysis of China's credit growth over the past six years or so would suggest that it is unsustainable and that as a result, when the day of...

Share
x